CPIX has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
CPIX has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Cumberland Pharmaceuticals's Long-Term Capital Lease Obligation for the quarter that ended in Mar. 2024 was $5.20 Mil.
Cumberland Pharmaceuticals's quarterly Long-Term Capital Lease Obligation declined from Sep. 2023 ($5.39 Mil) to Dec. 2023 ($5.30 Mil) and declined from Dec. 2023 ($5.30 Mil) to Mar. 2024 ($5.20 Mil).
Cumberland Pharmaceuticals's annual Long-Term Capital Lease Obligation increased from Dec. 2021 ($0.09 Mil) to Dec. 2022 ($4.59 Mil) and increased from Dec. 2022 ($4.59 Mil) to Dec. 2023 ($5.30 Mil).
The historical data trend for Cumberland Pharmaceuticals's Long-Term Capital Lease Obligation can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Cumberland Pharmaceuticals Annual Data | |||||||||||||||||||||
Trend | Dec14 | Dec15 | Dec16 | Dec17 | Dec18 | Dec19 | Dec20 | Dec21 | Dec22 | Dec23 | |||||||||||
Long-Term Capital Lease Obligation | Get a 7-Day Free Trial | 2.08 | 1.06 | 0.09 | 4.59 | 5.30 |
Cumberland Pharmaceuticals Quarterly Data | ||||||||||||||||||||
Jun19 | Sep19 | Dec19 | Mar20 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | Mar24 | |
Long-Term Capital Lease Obligation | Get a 7-Day Free Trial | 4.55 | 5.48 | 5.39 | 5.30 | 5.20 |
Cumberland Pharmaceuticals (NAS:CPIX) Long-Term Capital Lease Obligation Explanation
Long-Term Capital Lease Obligation are the amount due for long-term asset lease agreements that are nearly equivalent to asset purchases. Capital lease obligations are installment payments that constitute a payment of principal plus interest for the capital lease. The Short-Term Capital Lease Obligation is the portion of a Long-Term Capital Lease Obligation that is due over the next year.
Under US Generally Accepted Accounting Principles (GAAP), a capital lease is essentially equivalent to a purchase by the lessee if it meets the following criteria:
1. Ownership of the asset is transferred to the lessee at the end of the lease term;Thank you for viewing the detailed overview of Cumberland Pharmaceuticals's Long-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.
Todd M. Anthony | officer: Vice Pres Organizational Dev | 1600 WEST END AVENUE, SUITE 1300, NASHVILLE TN 37203 |
Chris T. Bitterman | officer: Vice Pres Sales & Marketing | 1600 WEST END AVENUE, SUITE 1300, NASHVILLE TN 37203 |
Joseph C Galante | director | 111 TENTH AVENUE, SUITE 200, NASHVILLE TN 37203 |
James Jones | director | 2525 WEST END AVE., SUITE 950, NASHVILLE TN 37203 |
Kenneth Krogulski | director | 2525 WEST END AVENUE, SUITE 950, NASHVILLE TN 37203 |
Caroline Young | director | 2525 WEST END AVENUE, SUITE 950, NASHVILLE TN 37203 |
Brown Martin S Jr | director | 850 DIXIE HIGHWAY, LOUISVILLE KY 40210 |
A J Kazimi | director, 10 percent owner, officer: Chairman and CEO | 1207 17TH AVENUE SUITE 103, NASHVILLE TN 37212 |
Martin E Cearnal | director | 31 UPPER MOUNTAIN AVENUE, APARTMENT 2, MONTCLAIR NJ 07042 |
John M. Hamm | officer: Chief Financial Officer | 2525 WEST END AVENUE, SUITE 950, NASHVILLE TN 37203 |
Gordon R Bernard | officer: Senior Vice President | 2525 WEST END AVENUE, SUITE 950, NASHVILLE TN 37203 |
Joey A Jacobs | director | 830 CRESCENT CENTER DRIVE, SUITE 610, FRANKLIN TN 37067 |
Michael Bonner | officer: Chief Financial Officer | 2525 WEST END AVENUE, SUITE 950, NASHVILLE TN 37203 |
Jonathan Griggs | director | 2525 WEST END AVENUE, SUITE 950, NASHVILLE TN 37203 |
Thomas R Lawrence | director | 1880 ELLINGTON WAY, AUBURN AL 36830 |
From GuruFocus
By PRNewswire PRNewswire • 05-29-2022
By PRNewswire • 10-10-2023
By PRNewswire PRNewswire • 11-29-2021
By PRNewswire PRNewswire • 08-02-2022
By PRNewswire PRNewswire • 08-03-2021
By PRNewswire PRNewswire • 06-18-2022
By PRNewswire • 08-08-2023
By PRNewswire PRNewswire • 05-03-2022
By PRNewswire PRNewswire • 05-15-2023
By PRNewswire PRNewswire • 05-19-2022
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.